MICROTRANSPONDER, INC.
Austin, TX · Founded 2007 · CIK 0001489993 · Medtech · Public
Vagus nerve stimulation (VNS) device paired with prolonged exposure therapy for PTSD treatment
mobia.com →- Grants
- $224K
- 1 award
- Sector median: 1
- Raised
- $108M
- 12 Form D · Mar 2025
- 19 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 2 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,999,530 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $500,080 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $2,679,538 | |
| Private capital raised | Form D · SEC | $1,266,992 | |
| Private capital raised | Form D · SEC | $3,057,225 | |
| Private capital raised | Form D · SEC | $3,895,682 | |
| Federal grant | Department of Health and Human Services · Phase I · An adjunct to prolonged exposure therapy for treating refractory PTSD patients | $224,257 | |
| Private capital raised | Form D · SEC | $5,525,976 | |
| Private capital raised | Form D · SEC | $11,586,919 | |
| Private capital raised | Form D · SEC | $5,750,000 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $32,948,732 | |
| Private capital raised | Form D · SEC | $32,499,977 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1217 | Angel Eye Camera Systems, LLC | — | $626K |
| 1218 | Cerillo, Inc | — | $3.8M |
| 1219 | EPICORE BIOSYSTEMS, INC. | — | $32M |
| 1220 | MICROTRANSPONDER, INC. | — | $108M |
| 1221 | TF Instruments | — | — |
| 1222 | Fresenius Medical Care Cedar Hill, LLC | — | $928K |
| 1223 | EFEMORAL MEDICAL, INC. | — | $4.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- N. CurnesDirector
- Nelson CurnesDirector · Executive Officer
- Thomas CurnesDirector
- T. Curnes IIDirector · Executive Officer
- Thomas Curnes IIDirector · Executive Officer
- Richard FoustDirector · Executive Officer
- Bill HarringtonDirector
- Cythia LuccheseDirector
- Frank McEachernDirector · Executive Officer
- Dana MeadDirector
- Chuck MiddlekaufDirector
- William RoselliniExecutive Officer
- Casey TanseyDirector
Patents
- Methods For Enhancing Exposure Therapy Using Pairing With Vagus Nerve Stimulationapplication
- Methods For Enhancing Exposure Therapy Using Pairing With Vagus Nerve Stimulationgranted
- Manipulation Member For Nerve Cuffgranted
- Transfer Coil Architectureapplication
- Grooved Electrode And Wireless Microtransponder Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.